HZNP
HZNP Articles
Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday included Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan and Switch.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm and Sirius XM.
Published:
Last Updated:
Here are 10 top Ireland-based public companies with shares that are traded in the United States that may be worth putting on a watchlist.
Published:
Last Updated:
These five top companies with different health care businesses all can provide nice exposure to the sector in growth portfolios. All are rated Buy at Jefferies and make sense now.
Published:
Last Updated:
24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential and probably don’t have the investment risk of some of the more...
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls include Archer Daniels Midland, BlackRock, DexCom, Mallinckrodt, McDonald's, Philip Morris and Redfin.
Published:
Last Updated:
Horizon Pharma released a better than expected quarterly earnings report before the markets opened on Monday.
Published:
Last Updated:
The analysts at Stifel have focused on biotech and specialty pharma companies that not only have data that could prove to be huge, but they are offering aggressive accounts the best entry points in...
Published:
Last Updated:
Pandora, Hertz, Horizon Pharma, and Chicago Bridge & Iron all posted new 52-week lows on Tuesday.
Published:
Last Updated:
Horizon Pharma, TherapeuticsMD, DDR Corp., and Cobalt Energy all posted new 52-week lows on Monday.
Published:
Last Updated:
Horizon Pharma PLC (NASDAQ: HZNP) saw its shares hit a 52-week low on Monday after the company released its first-quarter financial results. The company said that it had $0.21 in EPS and $220.9...
Published:
Last Updated:
The S&P 500 and Dow are pushing new highs as 2016 comes to a close. While the post-election tailwind has been incredibly strong, there are still companies holding back this rally.
Published:
Last Updated:
Horizon Pharma PLC saw its shares take a big step back on Thursday after the company reported topline results from one of its late-stage trials.
Published:
Last Updated:
Horizon Pharma PLC (NASDAQ: HZNP) reported its third-quarter financial results on Monday before the markets opened. The company said that it had $0.70 in earnings per share (EPS) and $208.7 million...
Published:
Last Updated: